AREN vs RNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 11, 2026
AREN
RNA
Investment Advisor Scores
RNA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | AREN | RNA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 13.369 | 0 | Tie |
| PEG Ratio | 1.1351 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -50.7% | -21.9% | RNA |
| Earnings Growth | -23.6% | 0.0% | RNA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 46.5/100 | 54.8/100 | RNA |
| Profit Margin | 9.3% | -184.1% | AREN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
AREN
DistributionPrice near a flattening SMA50 (slope -4.2%) with fading momentum, RSI 50
RNA
NeutralMixed signals - no dominant trend phase, RSI 32
Fundamentals Snapshot
| Metric | AREN | RNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 37.3 | -1.3 |
| Trailing P/E | 4.9 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.5% | -0.2% |
| Gross Margin | 0.4% | -0.6% |
| Operating Margin | 0.1% | -7.5% |
| EPS | 0.19 | -5.04 |
| Dividend Yield | — | — |